Mounjaro and Zepbound are one tirzepatide molecule sold under two Eli Lilly names. This explainer situates them within the wider incretin class, walks through the field's approvals, trials, and class-wide safety, explains April 2026 list pricing, and describes the pathway biology that no brand name on the pen ever alters.

This field-guide comparison places Ozempic and Mounjaro inside the wider incretin category, mapping FDA approvals across the class, decoding the trial acronyms, framing class-wide safety, explaining the April 2026 list-price range, and pointing to the genetic baseline that sits beneath every branded option a clinician might reach for.

Mounjaro's 2026 price is assembled from list price, coverage, savings cards, and compounded alternatives, which is why quoted figures vary so widely. This breakdown snapshots each input around the roughly $1,069 list price, so you can read any quoted number and tell which situation it actually describes.

Beyond the headlines, clinicians weigh Mounjaro against approvals, trial families, and safety limits before it fits into a weight plan. This page lays out what tirzepatide is, how the approvals stack up, which study programs inform decisions, and the genetic terrain that sits upstream of any compound choice.

A scenario-based walkthrough of Mounjaro cost: the published list price, followed by three realistic out-of-pocket situations, how coverage and savings cards reshape each one, how to find your own lane, and where compounded options fit, all reported as published for April 2026.

Shorthand searches like Mounjaro inj usually ask a format question: injection or pill, and what the labeled steps look like. This page explains why Mounjaro is injection-only right now, how injectable and oral GLP-1 formats compare, the labeled dose ladders, and the genetics underneath.

Mounjaro's real cost comes down to a handful of drivers working together. This checklist-style guide runs through list price, insurance and BMI gates, savings cards, discount coupons, and the compounded pathway, then adds the genetic context that price alone omits.

A Mounjaro prescription runs through evaluation, a matching FDA indication, a state-licensed pharmacy, dose titration, and follow-up. This guide walks each stage of the prescribing pathway, flags the illegitimate shortcuts to avoid, explains how compounded protocols compare, and shows where your genetic baseline fits before the first prescription.

Can you use an HSA on tirzepatide? Usually yes, when a licensed clinician prescribes it for a diagnosed condition. We compare how Eden, MEDVi, Ro, LillyDirect, and PlexusDx handle HSA at checkout, what 30–40% pre-tax savings looks like in real dollars, and where PlexusDx Tirzepatide Injection ($289/mo), Tirzepatide Oral ($349/mo), and GLP-Squared ($289/mo) fit. PlexusDx accepts HSA card payment where your plan permits and does not directly bill.

Every legitimate way to get a GLP-1 prescription in New York in 2026 — telehealth, PCP, obesity specialist, NYC clinic — with verified cash-pay pricing, NYRx Medicaid exclusion details, and where PlexusDx Weight Management Protocols ($129–$309/mo) fit relative to Wegovy and Zepbound.

The complete history of GLP-1 drugs — from 1902 incretin research to exenatide (2005), Victoza (2010), Ozempic (2017), Rybelsus (2019), Wegovy (2021), Mounjaro (2022), Zepbound (2023), and pipeline candidates orforglipron — with where PlexusDx Semaglutide, Tirzepatide, Microdose, and GLP-Squared protocols fit in 2026.

The honest 2026 trade-off on GLP-1 medications: substantial weight loss and cardiometabolic benefits balanced against GI side effects, cost, lean-mass loss risk, and long-term maintenance. Compares branded vs compounded options and where PlexusDx Weight Management Protocols fit at $129/mo to $349/mo across six protocols.

An honest read on the cons of GLP-1 therapy — GI side effects, the boxed warning, cost, weight regain on cessation, and body composition — plus where PlexusDx Weight Management Protocols ($129/mo to $349/mo, all 50 states, no membership) fit when insurance friction is itself one of the cons.

The cheapest GLP-1 without insurance online in 2026, ranked by 12-month cash-pay total. PlexusDx Microdose GLP-1 Protocol at $129/mo flat ($1,548/year) lands below Wegovy tablets, Tuyo Health, Breeze Meds, MEDVi, and Zepbound vials — with the optional Precision Peptide Genetic Test ($298) for genetics-anchored dosing.

Mounjaro cost without insurance runs $987–$1,112/month at U.S. pharmacies in April 2026. The $25 savings card requires commercial insurance, and Lilly Direct's $499 self-pay price is for Zepbound, not Mounjaro. PlexusDx Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan) is a compounded cash-pay alternative using the same active ingredient.

Mounjaro is FDA-approved tirzepatide for type 2 diabetes; Zepbound is the weight-loss-indicated brand. Compare branded Mounjaro online vs cash-pay compounded tirzepatide and where PlexusDx Tirzepatide Injection ($289/mo) fits.

Eight month-to-month GLP-1 providers compared against PlexusDx Weight Management Protocols on real annual cost, separate membership fees, intro-price cliffs, and genetic baseline. PlexusDx Microdose at $129/mo flat, Semaglutide Injection $189, Tirzepatide Injection $289, GLP-Squared $289 — all cash-pay, no membership.

Emerging research suggests GLP-1 receptor agonists like semaglutide and tirzepatide may reduce cravings for alcohol and other substances by modulating dopamine signaling in the brain’s reward circuitry — the same “food noise” mechanism that drives weight-loss outcomes. No GLP-1 is FDA-approved for any addiction indication. This guide explains what the human evidence actually shows, substance by substance, and how PlexusDx Weight Management Protocols are positioned for chronic weight management only.

Compounding pharmacy shut down or lost 503A status for GLP-1s? A 2026 patient continuity guide: first 24-hour checklist, the four scenarios, what a warning letter actually means, three pharmacy-verification lookups, and how PlexusDx Semaglutide Injection ($189/mo), Tirzepatide Injection ($289/mo), Microdose GLP-1 Protocol ($129/mo), GLP-Squared ($289/mo), and the Precision Peptide Genetic Test ($298) handle transfer patients.

The cheapest GLP-1 with insurance is roughly $25/month on Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo when your commercial plan covers the drug and you stack the manufacturer savings card. Only 43% of commercially insured users hit that scenario. When insurance won't cover a weight-loss GLP-1, PlexusDx cash-pay protocols start at $129/mo flat - cheaper than every branded self-pay route.

Step-by-step guide to getting a GLP-1 prescribed online in 2026: eligibility self-screen, the three pathways (insurance, branded cash-pay, compounded cash-pay), pharmacy verification, and how PlexusDx Weight Management Protocols handle the telehealth pathway in all 50 states with no membership fee.

Your GLP-1 protein target is 1.0–1.5 g/kg/day during active weight loss — meaningfully above the 0.8 g/kg RDA. This guide gives you the math, per-meal distribution, nausea-day food list, and where the PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 protocols sit relative to those targets.

FDA labels list hair loss in 3% of Wegovy and 4–5% of Zepbound users, but the real trigger is rapid weight loss producing telogen effluvium — a reversible 6–12 month shedding pattern. This guide covers the FDA evidence, the timeline you can plan around, why women report it more often, the genetic variants behind GLP-1 response, and how a slower-titration PlexusDx protocol plus the Precision Peptide Genetic Test reduces risk before week one.

The best tirzepatide online in 2026 depends on insurance status, format, and whether you want a genetic baseline guiding titration. Compare MEDVi, YUCCA Health, Willow, Eden, and TrimRx against PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo), with the optional Precision Peptide Genetic Test for pathway-level context.

The standard FDA tirzepatide dosing schedule moves through six weekly dose levels: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, with at least four weeks between steps. This guide walks the week-by-week ladder for both injection and oral compounded tirzepatide, the milligram-to-unit conversions for compounded vials, missed-dose rules, and how the GIPR rs1800437 genetic variant can inform titration pace before week one.

PA stuck on Wegovy, Zepbound, or Foundayo? The bridge options that won’t complicate your approval — LillyDirect from $299/mo, NovoCare from $149/mo, and the PlexusDx Microdose GLP-1 Protocol at $129/mo flat with no commitment.

Is oral tirzepatide FDA approved? No — only injectable Mounjaro and Zepbound are. Here's what compounded oral tirzepatide is, how PlexusDx Tirzepatide Oral ($349/mo) fits, and the safety considerations that apply to both.

Mounjaro side effects from the FDA-approved label — common GI reactions (nausea, vomiting, diarrhea, constipation, abdominal pain), less common serious reactions (pancreatitis, gallbladder disease, acute kidney injury), and the boxed warning for thyroid C-cell tumors with MTC and MEN 2 contraindications. Plus how compounded tirzepatide protocol oversight from PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo) compares, and where the Precision Peptide Genetic Test fits as $298 for GIPR, FTO, MC4R, and TCF7L2 baseline.

MEDVi vs Hers vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication source, tirzepatide availability across all three, cancellation and refund policy differences, and where the Precision Peptide Genetic Test fits when GLP-1 response varies by GIPR, FTO, MC4R, and TCF7L2 variants.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.